Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Egenskap
Dry skin
Skin characterized by the lack of natural or normal moisture.
Sammendrag
- Også kalt
- Xerosis
- Kroppssystem
- Abnormality of the integument
Dry skinHP:0000958
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Read the genes linked to Dry skin, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test214 gener knyttet til Dry skin
Endringer i disse genene forårsaker sjeldne tilstander der Dry skin forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| BANF1barrier to autointegration nuclear assembly factor 1 | Alltid | I 1 tilstand |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Alltid | I 5 tilstander |
| BUD13BUD13 spliceosome associated protein | Alltid | I 1 tilstand |
| CILK1ciliogenesis associated kinase 1 | Alltid | I 1 tilstand |
| CST6cystatin E/M | Alltid | I 1 tilstand |
| DBR1debranching RNA lariats 1 | Alltid | I 2 tilstander |
| EDAectodysplasin A | Alltid | I 1 tilstand |
| EDARADDEDAR associated via death domain | Alltid | I 4 tilstander |
| ELOVL1ELOVL fatty acid elongase 1 | Alltid | I 1 tilstand |
| ELOVL4ELOVL fatty acid elongase 4 | Alltid | I 2 tilstander |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Alltid | I 3 tilstander |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Alltid | I 2 tilstander |
| FDFT1farnesyl-diphosphate farnesyltransferase 1 | Alltid | I 1 tilstand |
| FEM1Bfem-1 homolog B | Alltid | I 1 tilstand |
| FLG2filaggrin 2 | Alltid | I 1 tilstand |
| GPNMBglycoprotein nmb | Alltid | I 1 tilstand |
| GTF2E2general transcription factor IIE subunit 2 | Alltid | I 2 tilstander |
| IKBKGinhibitor of nuclear factor kappa B kinase regulatory subunit gamma | Alltid | I 1 tilstand |
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Alltid | I 1 tilstand |
| NFKBIANFKB inhibitor alpha | Alltid | I 1 tilstand |
| PGM2L1phosphoglucomutase 2 like 1 | Alltid | I 1 tilstand |
| POLD3DNA polymerase delta 3, accessory subunit | Alltid | I 1 tilstand |
| POLR3ARNA polymerase III subunit A | Alltid | I 1 tilstand |
| PPP2R3Cprotein phosphatase 2 regulatory subunit B''gamma | Alltid | I 1 tilstand |
| RAP1BRAP1B, member of RAS oncogene family | Alltid | I 1 tilstand |
| RECQLRecQ like helicase | Alltid | I 1 tilstand |
| RNU2-2RNA, U2 small nuclear 2 | Alltid | I 1 tilstand |
| RNU6ATACRNA, U6atac small nuclear | Alltid | I 1 tilstand |
| SLC39A4solute carrier family 39 member 4 | Alltid | I 2 tilstander |
| SPINK5serine peptidase inhibitor Kazal type 5 | Alltid | I 2 tilstander |
| TGthyroglobulin | Alltid | I 1 tilstand |
| TM2D3TM2 domain containing 3 | Alltid | I 1 tilstand |
| TP63tumor protein p63 | Alltid | I 5 tilstander |
| TRIP4thyroid hormone receptor interactor 4 | Alltid | I 2 tilstander |
| UBE2Aubiquitin conjugating enzyme E2 A | Alltid | I 2 tilstander |
| WNT10AWnt family member 10A | Alltid | I 4 tilstander |
| YWHAZtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | Alltid | I 1 tilstand |
| ABCA12ATP binding cassette subfamily A member 12 | Svært ofte (80–99 %) | I 1 tilstand |
| ALDH3A2aldehyde dehydrogenase 3 family member A2 | Svært ofte (80–99 %) | I 1 tilstand |
| ALOX12Barachidonate 12-lipoxygenase, 12R type | Svært ofte (80–99 %) | I 1 tilstand |
Vis 174 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ALOXE3arachidonate epidermal lipoxygenase 3 | Svært ofte (80–99 %) | I 1 tilstand |
| ASPRV1aspartic peptidase retroviral like 1 | Svært ofte (80–99 %) | I 1 tilstand |
| ATP7AATPase copper transporting alpha | Svært ofte (80–99 %) | I 1 tilstand |
| CD28CD28 molecule | Svært ofte (80–99 %) | I 2 tilstander |
| CSTBcystatin B | Svært ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Svært ofte (80–99 %) | I 2 tilstander |
| CYP4F22cytochrome P450 family 4 subfamily F member 22 | Svært ofte (80–99 %) | I 1 tilstand |
| DDB2damage specific DNA binding protein 2 | Svært ofte (80–99 %) | I 1 tilstand |
| EDARectodysplasin A receptor | Svært ofte (80–99 %) | I 2 tilstander |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Svært ofte (80–99 %) | I 4 tilstander |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Svært ofte (80–99 %) | I 3 tilstander |
| ERCC5ERCC excision repair 5, endonuclease | Svært ofte (80–99 %) | I 2 tilstander |
| FLGfilaggrin | Svært ofte (80–99 %) | I 2 tilstander |
| GSNgelsolin | Svært ofte (80–99 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Svært ofte (80–99 %) | I 2 tilstander |
| LIPNlipase family member N | Svært ofte (80–99 %) | I 1 tilstand |
| MAP2K1mitogen-activated protein kinase kinase 1 | Svært ofte (80–99 %) | I 3 tilstander |
| MAP2K2mitogen-activated protein kinase kinase 2 | Svært ofte (80–99 %) | I 2 tilstander |
| NIPAL4NIPA like domain containing 4 | Svært ofte (80–99 %) | I 2 tilstander |
| PEPDpeptidase D | Svært ofte (80–99 %) | I 1 tilstand |
| PEX7peroxisomal biogenesis factor 7 | Svært ofte (80–99 %) | I 1 tilstand |
| PHYHphytanoyl-CoA 2-hydroxylase | Svært ofte (80–99 %) | I 1 tilstand |
| SDR9C7short chain dehydrogenase/reductase family 9C member 7 | Svært ofte (80–99 %) | I 1 tilstand |
| SMARCAD1SNF2 related chromatin remodeling ATPase with DExD box 1 | Svært ofte (80–99 %) | I 1 tilstand |
| STSsteroid sulfatase | Svært ofte (80–99 %) | I 1 tilstand |
| SULT2B1sulfotransferase family 2B member 1 | Svært ofte (80–99 %) | I 1 tilstand |
| TGM1transglutaminase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFRSF1BTNF receptor superfamily member 1B | Svært ofte (80–99 %) | I 2 tilstander |
| XPAXPA, DNA damage recognition and repair factor | Svært ofte (80–99 %) | I 1 tilstand |
| XPCXPC complex subunit, DNA damage recognition and repair factor | Svært ofte (80–99 %) | I 1 tilstand |
| ABCA1ATP binding cassette subfamily A member 1 | Ofte (30–79 %) | I 2 tilstander |
| ACDACD shelterin complex subunit and telomerase recruitment factor | Ofte (30–79 %) | I 1 tilstand |
| ADAadenosine deaminase | Ofte (30–79 %) | I 1 tilstand |
| ADARadenosine deaminase RNA specific | Ofte (30–79 %) | I 1 tilstand |
| ALKALK receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| BAP1BRCA1 associated deubiquitinase 1 | Ofte (30–79 %) | I 1 tilstand |
| BORCS8BLOC-1 related complex subunit 8 | Ofte (30–79 %) | I 1 tilstand |
| CASRcalcium sensing receptor | Ofte (30–79 %) | I 1 tilstand |
| CAV1caveolin 1 | Ofte (30–79 %) | I 1 tilstand |
| CDK4cyclin dependent kinase 4 | Ofte (30–79 %) | I 1 tilstand |
| CDKN2Acyclin dependent kinase inhibitor 2A | Ofte (30–79 %) | I 1 tilstand |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Ofte (30–79 %) | I 1 tilstand |
| CHD7chromodomain helicase DNA binding protein 7 | Ofte (30–79 %) | I 1 tilstand |
| CPLX1complexin 1 | Ofte (30–79 %) | I 1 tilstand |
| CTBP1C-terminal binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| DCLRE1CDNA cross-link repair 1C | Ofte (30–79 %) | I 1 tilstand |
| DOLKdolichol kinase | Ofte (30–79 %) | I 1 tilstand |
| DRG1developmentally regulated GTP binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| EXOC2exocyst complex component 2 | Ofte (30–79 %) | I 1 tilstand |
| GJA1gap junction protein alpha 1 | Ofte (30–79 %) | I 2 tilstander |
| GJB3gap junction protein beta 3 | Ofte (30–79 %) | I 1 tilstand |
| GJB4gap junction protein beta 4 | Ofte (30–79 %) | I 1 tilstand |
| GNA11G protein subunit alpha 11 | Ofte (30–79 %) | I 1 tilstand |
| GNB2G protein subunit beta 2 | Ofte (30–79 %) | I 1 tilstand |
| IFIH1interferon induced with helicase C domain 1 | Ofte (30–79 %) | I 1 tilstand |
| IL2RGinterleukin 2 receptor subunit gamma | Ofte (30–79 %) | I 1 tilstand |
| IL7Rinterleukin 7 receptor | Ofte (30–79 %) | I 1 tilstand |
| INSRinsulin receptor | Ofte (30–79 %) | I 2 tilstander |
| KDSR3-ketodihydrosphingosine reductase | Ofte (30–79 %) | I 1 tilstand |
| KRT1keratin 1 | Ofte (30–79 %) | I 1 tilstand |
| KRT14keratin 14 | Ofte (30–79 %) | I 1 tilstand |
| KYNUkynureninase | Ofte (30–79 %) | I 1 tilstand |
| LEF1lymphoid enhancer binding factor 1 | Ofte (30–79 %) | I 1 tilstand |
| LETM1leucine zipper and EF-hand containing transmembrane protein 1 | Ofte (30–79 %) | I 1 tilstand |
| LSM11LSM11, U7 small nuclear RNA associated | Ofte (30–79 %) | I 1 tilstand |
| MC1Rmelanocortin 1 receptor | Ofte (30–79 %) | I 1 tilstand |
| MGMTO-6-methylguanine-DNA methyltransferase | Ofte (30–79 %) | I 1 tilstand |
| MITFmelanocyte inducing transcription factor | Ofte (30–79 %) | I 1 tilstand |
| NELFAnegative elongation factor complex member A | Ofte (30–79 %) | I 1 tilstand |
| NKX2-5NK2 homeobox 5 | Ofte (30–79 %) | I 1 tilstand |
| NLRP1NLR family pyrin domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| NOD2nucleotide binding oligomerization domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| NRASNRAS proto-oncogene, GTPase | Ofte (30–79 %) | I 1 tilstand |
| NSD2nuclear receptor binding SET domain protein 2 | Ofte (30–79 %) | I 1 tilstand |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| NUDCD3NudC domain containing 3 | Ofte (30–79 %) | I 1 tilstand |
| PAX8paired box 8 | Ofte (30–79 %) | I 2 tilstander |
| PCNTpericentrin | Ofte (30–79 %) | I 1 tilstand |
| PIGGphosphatidylinositol glycan anchor biosynthesis class G (EMM blood group) | Ofte (30–79 %) | I 1 tilstand |
| PIGHphosphatidylinositol glycan anchor biosynthesis class H | Ofte (30–79 %) | I 1 tilstand |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Ofte (30–79 %) | I 1 tilstand |
| POLHDNA polymerase eta | Ofte (30–79 %) | I 1 tilstand |
| PORCNporcupine O-acyltransferase | Ofte (30–79 %) | I 1 tilstand |
| POT1protection of telomeres 1 | Ofte (30–79 %) | I 1 tilstand |
| PRKD1protein kinase D1 | Ofte (30–79 %) | I 1 tilstand |
| PSMB10proteasome 20S subunit beta 10 | Ofte (30–79 %) | I 1 tilstand |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Ofte (30–79 %) | I 3 tilstander |
| RAG1recombination activating 1 | Ofte (30–79 %) | I 1 tilstand |
| RAG2recombination activating 2 | Ofte (30–79 %) | I 1 tilstand |
| RIPK4receptor interacting serine/threonine kinase 4 | Ofte (30–79 %) | I 2 tilstander |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Ofte (30–79 %) | I 1 tilstand |
| RNASEH2Aribonuclease H2 subunit A | Ofte (30–79 %) | I 1 tilstand |
| RNASEH2Bribonuclease H2 subunit B | Ofte (30–79 %) | I 1 tilstand |
| RNASEH2Cribonuclease H2 subunit C | Ofte (30–79 %) | I 1 tilstand |
| RNU7-1RNA, U7 small nuclear 1 | Ofte (30–79 %) | I 2 tilstander |
| SAMHD1SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | Ofte (30–79 %) | I 2 tilstander |
| SASH1SAM and SH3 domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| SOX5SRY-box transcription factor 5 | Ofte (30–79 %) | I 1 tilstand |
| SRD5A3steroid 5 alpha-reductase 3 | Ofte (30–79 %) | I 1 tilstand |
| TERF2IPTERF2 interacting protein | Ofte (30–79 %) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Ofte (30–79 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Ofte (30–79 %) | I 1 tilstand |
| TRHRthyrotropin releasing hormone receptor | Ofte (30–79 %) | I 1 tilstand |
| TRPM1transient receptor potential cation channel subfamily M member 1 | Ofte (30–79 %) | I 1 tilstand |
| TSHBthyroid stimulating hormone subunit beta | Ofte (30–79 %) | I 2 tilstander |
| TSHZ3teashirt zinc finger homeobox 3 | Ofte (30–79 %) | I 1 tilstand |
| TWIST2twist family bHLH transcription factor 2 | Ofte (30–79 %) | I 3 tilstander |
| WNT10BWnt family member 10B | Ofte (30–79 %) | I 1 tilstand |
| ZEB2zinc finger E-box binding homeobox 2 | Ofte (30–79 %) | I 1 tilstand |
| AARS1alanyl-tRNA synthetase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ALG11ALG11 alpha-1,2-mannosyltransferase | Noen ganger (5–29 %) | I 1 tilstand |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Noen ganger (5–29 %) | I 1 tilstand |
| BCKDKbranched chain keto acid dehydrogenase kinase | Noen ganger (5–29 %) | I 1 tilstand |
| CAMK2Bcalcium/calmodulin dependent protein kinase II beta | Noen ganger (5–29 %) | I 1 tilstand |
| CARS1cysteinyl-tRNA synthetase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CASTcalpastatin | Noen ganger (5–29 %) | I 1 tilstand |
| COG6component of oligomeric golgi complex 6 | Noen ganger (5–29 %) | I 1 tilstand |
| CTSCcathepsin C | Noen ganger (5–29 %) | I 1 tilstand |
| DDOSTdolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit | Noen ganger (5–29 %) | I 1 tilstand |
| DPP9dipeptidyl peptidase 9 | Noen ganger (5–29 %) | I 1 tilstand |
| FBXO22F-box protein 22 | Noen ganger (5–29 %) | I 1 tilstand |
| FGFR1fibroblast growth factor receptor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| FOSL2FOS like 2, AP-1 transcription factor subunit | Noen ganger (5–29 %) | I 1 tilstand |
| GABBR1gamma-aminobutyric acid type B receptor subunit 1 | Noen ganger (5–29 %) | I 1 tilstand |
| GINS1GINS complex subunit 1 | Noen ganger (5–29 %) | I 1 tilstand |
| GTF2H5general transcription factor IIH subunit 5 | Noen ganger (5–29 %) | I 1 tilstand |
| GTF3C3general transcription factor IIIC subunit 3 | Noen ganger (5–29 %) | I 1 tilstand |
| HESX1HESX homeobox 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IDH1isocitrate dehydrogenase (NADP(+)) 1 | Noen ganger (5–29 %) | I 1 tilstand |
| KCTD1potassium channel tetramerization domain containing 1 | Noen ganger (5–29 %) | I 1 tilstand |
| KIF11kinesin family member 11 | Noen ganger (5–29 %) | I 1 tilstand |
| KIF15kinesin family member 15 | Noen ganger (5–29 %) | I 1 tilstand |
| MAPK1mitogen-activated protein kinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Noen ganger (5–29 %) | I 2 tilstander |
| MPLKIPM-phase specific PLK1 interacting protein | Noen ganger (5–29 %) | I 1 tilstand |
| MYSM1Myb like, SWIRM and MPN domains 1 | Noen ganger (5–29 %) | I 2 tilstander |
| NOTCH2notch receptor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ODC1ornithine decarboxylase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| OFD1OFD1 centriole and centriolar satellite protein | Noen ganger (5–29 %) | I 1 tilstand |
| OTX2orthodenticle homeobox 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PROKR2prokineticin receptor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| RALGAPA1Ral GTPase activating protein catalytic subunit alpha 1 | Noen ganger (5–29 %) | I 1 tilstand |
| RNF113Aring finger protein 113A | Noen ganger (5–29 %) | I 1 tilstand |
| RNU4ATACRNA, U4atac small nuclear | Noen ganger (5–29 %) | I 1 tilstand |
| SATB1SATB homeobox 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SKIC2SKI2 subunit of superkiller complex | Noen ganger (5–29 %) | I 1 tilstand |
| SKIC3SKI3 subunit of superkiller complex | Noen ganger (5–29 %) | I 1 tilstand |
| SLF2SMC5/6 complex localization factor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| SMG8SMG8 nonsense mediated mRNA decay factor | Noen ganger (5–29 %) | I 1 tilstand |
| SOX2SRY-box transcription factor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| SOX3SRY-box transcription factor 3 | Noen ganger (5–29 %) | I 1 tilstand |
| SPENspen family transcriptional repressor | Noen ganger (5–29 %) | I 1 tilstand |
| SPRED2sprouty related EVH1 domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TARS1threonyl-tRNA synthetase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TTC5tetratricopeptide repeat domain 5 | Noen ganger (5–29 %) | I 1 tilstand |
| ZNF341zinc finger protein 341 | Noen ganger (5–29 %) | I 1 tilstand |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Sjelden (1–4%) | I 1 tilstand |
| RYR1ryanodine receptor 1 | Sjelden (1–4%) | I 1 tilstand |
| CLDN1claudin 1 | Ikke registrert | I 1 tilstand |
| CLDN10claudin 10 | Ikke registrert | I 1 tilstand |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Ikke registrert | I 1 tilstand |
| FUCA1alpha-L-fucosidase 1 | Ikke registrert | I 1 tilstand |
| IFT43intraflagellar transport 43 | Ikke registrert | I 1 tilstand |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Ikke registrert | I 1 tilstand |
| MPDU1mannose-P-dolichol utilization defect 1 | Ikke registrert | I 1 tilstand |
| NAGAalpha-N-acetylgalactosaminidase | Ikke registrert | I 1 tilstand |
| OSMRoncostatin M receptor | Ikke registrert | I 1 tilstand |
| PAHphenylalanine hydroxylase | Ikke registrert | I 1 tilstand |
| PEX11Bperoxisomal biogenesis factor 11 beta | Ikke registrert | I 1 tilstand |
| RNF168ring finger protein 168 | Ikke registrert | I 1 tilstand |
| SLC5A5solute carrier family 5 member 5 | Ikke registrert | I 1 tilstand |
| THRAthyroid hormone receptor alpha | Ikke registrert | I 1 tilstand |
| TINF2TERF1 interacting nuclear factor 2 | Ikke registrert | I 1 tilstand |
| UVSSAUV stimulated scaffold protein A | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker